Parallel Advisors’s National Healthcare NHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $142K | Hold |
673
| – | – | ﹤0.01% | 1487 |
|
|
2026
Q1 | $107K | Buy |
673
+6
| +0.9% | +$921 | ﹤0.01% | 1549 |
|
|
2025
Q4 | $91.4K | Buy |
667
+26
| +4% | +$3.36K | ﹤0.01% | 1517 |
|
|
2025
Q3 | $77.9K | Sell |
641
-19
| -3% | -$2.05K | ﹤0.01% | 1546 |
|
|
2025
Q2 | $70.6K | Buy |
660
+35
| +6% | +$3.5K | ﹤0.01% | 1542 |
|
|
2025
Q1 | $58K | Sell |
625
-68
| -10% | -$6.59K | ﹤0.01% | 1547 |
|
|
2024
Q4 | $74.5K | Sell |
693
-78
| -10% | -$9.49K | ﹤0.01% | 1416 |
|
|
2024
Q3 | $97K | Buy |
771
+14
| +2% | +$1.76K | ﹤0.01% | 1272 |
|
|
2024
Q2 | $82.1K | Sell |
757
-2
| -0.3% | -$195 | ﹤0.01% | 1270 |
|
|
2024
Q1 | $71.7K | Buy |
759
+87
| +13% | +$8.24K | ﹤0.01% | 1322 |
|
|
2023
Q4 | $62.1K | Sell |
672
-162
| -19% | -$12.4K | ﹤0.01% | 1341 |
|
|
2023
Q3 | $53.4K | Buy |
834
+140
| +20% | +$8.97K | ﹤0.01% | 1364 |
|
|
2023
Q2 | $42.9K | Buy |
694
+394
| +131% | +$23.4K | ﹤0.01% | 1477 |
|
|
2023
Q1 | $17.4K | Buy |
300
+278
| +1,264% | +$16K | ﹤0.01% | 1902 |
|
|
2022
Q4 | $1.31K | Sell |
22
-285
| -93% | -$17.3K | ﹤0.01% | 2826 |
|
|
2022
Q3 | $19K | Sell |
307
-9
| -3% | -$625 | ﹤0.01% | 1705 |
|
|
2022
Q2 | $22K | Sell |
316
-64
| -17% | -$4.48K | ﹤0.01% | 1628 |
|
|
2022
Q1 | $27K | Buy |
380
+41
| +12% | +$2.76K | ﹤0.01% | 1582 |
|
|
2021
Q4 | $23K | Buy |
339
+55
| +19% | +$3.81K | ﹤0.01% | 1715 |
|
|
2021
Q3 | $20K | Buy |
284
+94
| +49% | +$6.84K | ﹤0.01% | 1737 |
|
|
2021
Q2 | $13K | Hold |
190
| – | – | ﹤0.01% | 1900 |
|
|
2021
Q1 | $15K | Sell |
190
-191
| -50% | -$13.5K | ﹤0.01% | 1738 |
|
|
2020
Q4 | $25K | Buy |
381
+50
| +15% | +$3.29K | ﹤0.01% | 1389 |
|
|
2020
Q3 | $21K | Sell |
331
-25
| -7% | -$1.56K | ﹤0.01% | 1423 |
|
|
2020
Q2 | $22K | Sell |
356
-807
| -69% | -$54.1K | ﹤0.01% | 1382 |
|
|
2020
Q1 | $83K | Sell |
1,163
-1,238
| -52% | -$97.9K | 0.01% | 755 |
|
|
2019
Q4 | $208K | Sell |
2,401
-170
| -7% | -$14.2K | 0.02% | 502 |
|
|
2019
Q3 | $210K | Buy |
2,571
+823
| +47% | +$68.1K | 0.02% | 459 |
|
|
2019
Q2 | $142K | Buy |
1,748
+1,591
| +1,013% | +$123K | 0.01% | 547 |
|
|
2019
Q1 | $12K | Buy |
157
+55
| +54% | +$4.36K | ﹤0.01% | 1453 |
|
|
2018
Q4 | $8K | Buy |
+102
| New | +$7.99K | ﹤0.01% | 1413 |
|
Other funds holding NHC
MSIIA
Parallel Advisors's NHC Position: Q2 2026 in Review
Parallel Advisors held its National Healthcare (NHC) position steady in Q2 2026 at 673 shares worth $142K. The position accounts for ﹤0.01% of the portfolio, ranked #1487.
Parallel Advisors first reported a position in NHC in Q4 2018 and has held it in 31 quarters since. The position peaked at $210K in Q3 2019. 249 funds tracked by Wall St. Rank hold NHC as of Q2 2026.
- Parallel Advisors held 673 shares of National Healthcare worth $142K as of Q2 2026.
- Parallel Advisors left its National Healthcare share count unchanged in Q2 2026.
- National Healthcare made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #1487 holding.
- Parallel Advisors first reported a position in National Healthcare in Q4 2018 and has held it in 31 quarters since.
- Parallel Advisors's National Healthcare position peaked at $210K in Q3 2019.
- 249 funds tracked by Wall St. Rank held National Healthcare as of Q2 2026.
Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.